First Experience With 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the Netherlands
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000002561
Abstract: Purpose The present study summarizes the first experience with 177Lu-PSMA-617 (177Lu-PSMA) treatment in metastatic castration-resistant prostate cancer (PCa) in our institution. Methods This was an analysis of the first 30 consecutive patients who underwent 177Lu-PSMA… read more here.
Keywords: therapy; first experience; prostate; psma ... See more keywords